Marine Biotechnology Companies and Mergers and Acquisitions (M&A)

Top Companies in the Marine Biotechnology Market

• PharmaMar S.A.
• Cyanotech Corporation
• AstaReal Co., Ltd.
• Marinomed Biotech AG
• AlgaEnergy
• Corbion
• Kerecis
• Cyanotech/first up
• Coral Vita/reef-restoration & marine bioengineering innovators
• Aphios Corporation
• AMSILK/bio-materials innovators
• Mara Renewables/Mara Seaweed
• Phytoplankton/AlgaSpring
• Hatch Blue/aquaculture biotech & feed tech startups
• Cyanovation/Cyanotech-like regional players
• BlueBioTech/small to mid-cap marine biotech firms
• SeaBeLife Biotech
• Kitozyme/suppliers of marine polysaccharides
• Large ingredient distributors

Market Growth

The global marine biotechnology market size is calculated at US$ 6.72 billion in 2024, grew to US$ 7.21 billion in 2025, and is projected to reach around US$ 13.25 billion by 2034. The market is expanding at a CAGR of 7.24% between 2025 and 2034.

What are the Major Trends in the Marine Biotechnology Market?

• Ongoing technological advancements, like AI and ML, along with the wider investment, collaborations in marine nutraceuticals and pharmaceuticals, are accelerating the prospective market transformation.
• In September 2025, Biomaterials company Marine Biologics partnered with Molecular Quantum Solutions (MQS) to commercialize MQS’ physics-based modeling and machine learning tools as applied to marine-derived bioproducts. 
• In September 2025, MarinTrust and the Sustainable Fisheries Partnership (SFP) signed a Memorandum of Understanding (MoU) focusing on further developing their work together on the responsible sourcing of marine ingredients.
• In October 2024, the Blue Revolution Fund (BRF) raised €93 million for aquaculture investment.

Latest Announcements by Industry Leaders

• In August 2025, the SAARC Development Fund (SDF) announced an alliance with national institutions and technical agencies from five SAARC Member States to introduce the AquaLivelihood Project in Colombo, Sri Lanka. Minister Chandrasekar said that this will be a revolutionary journey toward a resilient future for small-scale farmers.
• In February 2025, Microalgae protein pioneer Brevel, Ltd., announced it had signed a development and commercialization agreement with the largest Israeli beverage company to produce functional beverages and dairy alternatives containing Brevel's high-value microalgae protein and oils. Yonatan Golan, Brevel's co-founder and CEO, commented that this co-venture will be instrumental in sustaining Brevel at the forefront of evolutions in food-tech and climate-tech.

Recent Developments in the Marine Biotechnology Market

• In August 2025, Singapore-based Umami Bioworks introduced its AI-led cell cultivation platform to develop sustainable marine bioactives for use in the personal care and nutraceutical industries.
• In April 2025, Omega-3-rich krill oil provider Aker BioMarine unveiled Revervia, a novel algae-based DHA oil suitable for dietary supplements.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com